Leukemia

FDA approves 'breakthrough therapy' for CLL

FDA approves 'breakthrough therapy' for CLL

Gazyva is designed to bolster the immune system's ability to attack cancer cells.

Is there an occupational cancer risk with flying?

Is there an occupational cancer risk with flying?

By

Has any research been conducted to determine whether the incidence of various types of skin cancer is greater in people who fly for a living compared with the general public?

Gleevec approved for pediatric acute lymphoblastic leukemia

Gleevec approved for pediatric acute lymphoblastic leukemia

Imatinib belongs to a class of drugs called tyrosine kinase inhibitors and blocks proteins that promote development of cancer cells.

Ponatinib wins early approval for rare leukemias

Ponatinib wins early approval for rare leukemias

The FDA has approved ponatinib to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Bosutinib approved for chronic myelogenous leukemia

Bosutinib approved for chronic myelogenous leukemia

The FDA has approved bosutinib (Bosulif, Pfizer) for patients with chronic, accelerated or blast phase Philadelphia chromosome positive CML, who are resistant to or who cannot tolerate other therapies.

Presyncope coupled with an enlarged spleen suggests infection

Presyncope coupled with an enlarged spleen suggests infection

A 69-year-old woman presents with night sweats, dizziness, fatigue and chronic pain in the upper abdomen.

CT scans up leukemia, brain tumor risk in young

CT scans up leukemia, brain tumor risk in young

Children and young adults who had computer tomography (CT) scans of the head had a small but increased risk of later leukemia and brain cancer, data indicate.

Sign Up for Free e-newsletters